NCT04676360 2026-03-13Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell LymphomaMassachusetts General HospitalPhase 2 Terminated10 enrolled 11 charts
NCT03038672 2025-11-10Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell LymphomasNational Cancer Institute (NCI)Phase 2 Active not recruiting54 enrolled 12 charts
NCT02797470 2025-04-20Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantAIDS Malignancy ConsortiumPhase 1/2 Active not recruiting11 enrolled 9 charts